Aortic and mitral bioprosthetic valve dysfunction: surgical or percutaneous solutions?

Area of Science:

• Cardiology
• Biomedical Engineering
• Surgical Innovation

Background:

• Growing preference for biological prostheses in younger patients to avoid anticoagulant therapy.
• Established long-term durability of surgical tissue valves.
• Younger age identified as a key risk factor for structural valve deterioration (SVD).

Purpose of the Study:

• Address the rising incidence of valve dysfunction due to SVD in younger populations.
• Explore alternative treatment options beyond surgical reintervention for prosthesis deterioration.
• Investigate the role of transcatheter heart valves in managing SVD, especially in high-risk patients.

Main Methods:

• Review of trends in biological prosthesis preference among young patients.
• Analysis of risk factors associated with structural valve deterioration (SVD).
• Evaluation of transcatheter heart valve technology as a less invasive reintervention option.

Main Results:

• Younger patients face increased risk of SVD despite biological valve durability.
• Surgical reintervention remains the standard for prosthesis deterioration.
• Transcatheter heart valves present a promising, less invasive alternative for high-risk patients.

Conclusions:

• The increasing prevalence of SVD in younger patients necessitates advanced therapeutic strategies.
• Transcatheter interventions offer a viable, less invasive approach for managing valve deterioration.
• Standardized definitions of valve durability will improve understanding and guide prosthesis selection for valve replacement.